Axogen Non Current Liabilities Total from 2010 to 2024

AXGN Stock  USD 12.64  0.17  1.36%   
Axogen Non Current Liabilities Total yearly trend continues to be very stable with very little volatility. Non Current Liabilities Total is likely to grow to about 74.3 M this year. During the period from 2010 to 2024, Axogen Non Current Liabilities Total quarterly data regression pattern had sample variance of 790.2 T and median of  25,201,157. View All Fundamentals
 
Non Current Liabilities Total  
First Reported
1987-06-30
Previous Quarter
69.8 M
Current Value
69.5 M
Quarterly Volatility
22.4 M
 
Oil Shock
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Axogen financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Axogen's main balance sheet or income statement drivers, such as Depreciation And Amortization of 5.8 M, Interest Expense of 1.6 M or Total Revenue of 167 M, as well as many indicators such as Price To Sales Ratio of 1.75, Dividend Yield of 1.39 or PTB Ratio of 2.91. Axogen financial statements analysis is a perfect complement when working with Axogen Valuation or Volatility modules.
  
Check out the analysis of Axogen Correlation against competitors.

Latest Axogen's Non Current Liabilities Total Growth Pattern

Below is the plot of the Non Current Liabilities Total of Axogen Inc over the last few years. It is Axogen's Non Current Liabilities Total historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Axogen's overall financial position and show how it may be relating to other accounts over time.
Non Current Liabilities Total10 Years Trend
Slightly volatile
   Non Current Liabilities Total   
       Timeline  

Axogen Non Current Liabilities Total Regression Statistics

Arithmetic Mean32,478,828
Geometric Mean13,847,844
Coefficient Of Variation86.55
Mean Deviation23,976,461
Median25,201,157
Standard Deviation28,110,452
Sample Variance790.2T
Range74.1M
R-Value0.78
Mean Square Error339.7T
R-Squared0.60
Significance0.0007
Slope4,872,055
Total Sum of Squares11062.8T

Axogen Non Current Liabilities Total History

202474.3 M
202370.7 M
202270.6 M
202171.2 M
202055.4 M
20191.6 M
2018147 K

About Axogen Financial Statements

Axogen investors utilize fundamental indicators, such as Non Current Liabilities Total, to predict how Axogen Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Non Current Liabilities Total70.7 M74.3 M

Pair Trading with Axogen

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Axogen position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Axogen will appreciate offsetting losses from the drop in the long position's value.

Moving against Axogen Stock

  0.52GH Guardant HealthPairCorr
  0.49DXCM DexCom IncPairCorr
  0.41SNDA Sonida Senior LivingPairCorr
  0.39AGL agilon healthPairCorr
  0.37MBOT Microbot MedicalPairCorr
The ability to find closely correlated positions to Axogen could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Axogen when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Axogen - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Axogen Inc to buy it.
The correlation of Axogen is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Axogen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Axogen Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Axogen can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Axogen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Axogen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Axogen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Axogen Inc Stock:
Check out the analysis of Axogen Correlation against competitors.
You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Axogen. If investors know Axogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Axogen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.33)
Revenue Per Share
4.16
Quarterly Revenue Growth
0.179
Return On Assets
(0.03)
Return On Equity
(0.15)
The market value of Axogen Inc is measured differently than its book value, which is the value of Axogen that is recorded on the company's balance sheet. Investors also form their own opinion of Axogen's value that differs from its market value or its book value, called intrinsic value, which is Axogen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Axogen's market value can be influenced by many factors that don't directly affect Axogen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Axogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Axogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Axogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.